English | 繁體

Search in the results

UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling Journal article
Gong, Shaolin, Sui, Yuan, Xiao, Mengxuan, Fu, Daoyao, Xiong, Zhiping, Zhang, Liuping, Tian, Qingshan, Fu, Yongnan, Xiong, Wenjun. Canagliflozin mediates mitophagy through the AMPK/PINK1/PARKIN pathway to alleviate isoprenaline-induced cardiac remodelling[J]. Journal of Cardiovascular Pharmacology, 2024, 84(5), 496-505.
Authors:  Gong, Shaolin;  Sui, Yuan;  Xiao, Mengxuan;  Fu, Daoyao;  Xiong, Zhiping; et al.
Favorite | TC[WOS]:1 TC[Scopus]:0  IF:2.6/2.5 | Submit date：2024/09/03
Canagliflozin  Cardiac Remodeling  Cardioprotective  Mitophagy  Sglt-2 Inhibitor  
Targeting mitophagy as a novel therapeutic approach in liver cancer Journal article
Ji Feng, Jing Zhou, Yong Wu, Han-Ming Shen, Tao Peng, Guo-Dong Lu. Targeting mitophagy as a novel therapeutic approach in liver cancer[J]. Autophagy, 2022, 19(7), 2164-2165.
Authors:  Ji Feng;  Jing Zhou;  Yong Wu;  Han-Ming Shen;  Tao Peng; et al.
Favorite | TC[WOS]:8 TC[Scopus]:8  IF:14.6/16.8 | Submit date：2023/01/30
Canagliflozin  Glucose Restriction  Hcc  Mitophagy  Sorafenib